TELA Bio (TELA)
(Delayed Data from NSDQ)
$1.62 USD
+0.03 (1.89%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.62 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2025
Time: -- |
9/2025 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, TELA Bio (TELA) reported earnings of -$0.22 per share, missing the Zacks Consensus Estimate of -$0.18 per share. This reflects a negative earnings surprise of 22.22%. Look out for TELA's next earnings release expected on November 06, 2025. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 59.52%.
Earnings History
Price & Consensus
Zacks News for TELA
Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates
TELA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates
NeoGenomics (NEO) Meets Q2 Earnings Estimates
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
TELA FAQs
Based on past history, Zacks believes TELA Bio, Inc. (TELA) will report their next quarter earnings on November 06, 2025. For the next earning release, we expect the company to report earnings of -0.17 per share, reflecting a year-over-year increase of 59.52.
Based on past history, Zacks believes TELA Bio, Inc. (TELA) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on November 06, 2025.
The Zacks Consensus Estimate for TELA Bio, Inc. (TELA) for the quarter ending September 2025 is $-0.17 a share. We expect TELA Bio, Inc. (TELA) to report earnings in line with the consensus estimate of $-0.17 per share
In the earnings report for the quarter ending in June 2024, TELA Bio, Inc. (TELA) announced earnings of $-0.51 per share versus the Zacks Consensus Estimate of $-0.45 per share, representing a surprise of 13.33%.